Skip to content
REH
Tissue
Peripheral blood
Disease
Acute lymphoblastic leukemia (ALL)
Synonyms
Reh

Documents

REH

Cell line · Product number 300320

REH is a human B-cell precursor acute lymphoblastic leukemia (ALL) cell line derived in 1973 from the peripheral blood of a 15-year-old patient during rel...

€430.00excl. tax and shipping

Customization / Recommendations

In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

REH is a human B-cell precursor acute lymphoblastic leukemia (ALL) cell line derived in 1973 from the peripheral blood of a 15-year-old patient during relapse. As one of the earliest established B-precursor ALL models, it displays typical lymphoblastic morphology and grows in suspension culture, reflecting the behavior of leukemia blasts.

REH cells are widely used to investigate B-ALL biology, including proliferation, survival pathways, and treatment response. They support both in vitro drug-screening studies and in vivo leukemia modeling through xenograft experiments in immunodeficient mice, making them a versatile tool for preclinical research on novel therapeutic strategies.

Tissue
Peripheral blood
Disease
Acute lymphoblastic leukemia (ALL)
Synonyms
  • Reh

02Classification

Organism
Human
Sex
Female
Growth properties
Adherent
Biosafety level
1

03Characteristics

Morphology
Round cells
Cell type
Lymphoblast

04Identifiers

Citation
REH (Cytion catalog number 300320)
NCBI TaxID
9606
Cellosaurus
CVCL_1650

05Expression and susceptibility

Antigen expression
CD3 A (17%) B (17%) C (20%), CD4 (15%), CD10 (55%), CD20+, HLA-DR+, CALLA+

06Handling and culture

Culture medium
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% heat-inactivated FBS
Dissociation reagent
Accutase
Subculturing
Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth.
Fluid renewal
2 to 3 times per week
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
15 years
Ethnicity
Caucasian